FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend

Sep.20.2024
FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT, a leading e-cigarette brand in Germany, shares market insights at InterTabac amid strict regulations and growing competition.

On September 19th, 2024, the InterTabac tobacco exhibition in Dortmund, Germany officially opened. On the opening day, 2Firsts conducted an exclusive interview with the popular e-cigarette brand FUMOT.

FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT's best-selling product in Germany | Image source: 2Firsts

 

FUMOT staff briefed 2Firsts on the current situation in the German market. According to their information, leading brands in the compliant German market include ELFBAR, BLU, HQD, and FLERBAR. Additionally, FUMOT's flagship products have achieved shipments of several million units in the German market, making it their key market.

 

FUMOT Interview: Germany's Grey Market Shifts Online, '2+10' Products Emerge as Trend
FUMOT's new "2+10" products | Image source: 2Firsts

 

When discussing the mainstream product types in the German market, the staff member stated that due to factors such as low cost-effectiveness, small-sized disposable products have seen a significant decrease in market share in Germany, becoming increasingly marginalized. Conversely, new large-sized disposable products that comply with TPD standards are emerging, such as innovative products like "n in 1" and "2+10." Therefore, at this trade show, FUMOT also introduced a variety of innovative products like "2+10" to meet the demands of the German market and solidify its market position.

 

For brands looking to enter the German market, the staff member believes that although Germany is an important market in Europe with promising prospects, the acceptance of new brands is relatively low. Distributors tend to prefer familiar brands. Therefore, achieving success in the German market requires long-term cultivation and careful planning.

 

When it comes to regulation, the above-mentioned staff shared the regulatory situation of the e-cigarette market in Germany. According to their information, Germany imposes high taxes on e-liquid products, with a tax of 2 euros per compliant 10ml e-liquid. German police also conduct strict inspections of tax labels attached to products at the retail end. Among them, Berlin has the highest inspection frequency in the market, but the penalties for violations are relatively light, usually limited to confiscation of goods or fines. In contrast, the market in Cologne has the strictest regulation, and sellers of tax evasion products may face criminal liability.

 

According to reports, despite this, there are still underground markets in Germany, but these markets mainly operate through online channels such as WhatsApp and Instagram. Due to the high risks involved in offline transactions, only a few retail stores dare to get involved, and they usually only sell to trusted customers.

 

In the interview, FUMOT's onsite staff repeatedly mentioned the keyword "compliance." They believe that with the increasing strictness of market supervision in Germany, brands must actively align with compliance standards in order to achieve long-term stable development.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
India Duty-Free Nicotine Pouch Sales Face Regulatory Test as ZYN, FOX Classification Remains Open
The Bombay High Court has ruled that airport duty-free shops are not exempt from India's domestic regulatory laws merely because they operate beyond the customs barrier, leaving in place a sales halt covering ZYN and FOX nicotine pouches at Mumbai's international airport. The court, however, did not determine that the products necessarily qualify as "drugs" under India's Drugs and Cosmetics Act. The retailers have four weeks to submit product information to the appropriate authorities, including CDSCO, which must complete its review within 30 days of receiving the submissions.
Sep.24
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation, linked to IMiracle and ELFBAR, wins China patent for 6-methylnicotine salts covering vaping and oral products
HG Innovation Limited has been granted a Chinese invention patent covering 6-methylnicotine salt formulations and their use in oral and vaping products. The technology forms salts between 6-methylnicotine and alicyclic carboxylic acids, with granted claims extending to oral products, atomization substrates and electronic atomization devices. Applicant-generated tests reported differences in oxidation stability, in-vitro cytotoxicity and aerosol heavy-metal performance compared with selected benzoate or lactate controls. HG Innovation is directly linked to the broader IMiracle and ELFBAR business network.
Sep.04
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea Imports 12,126 Kg of Nicotine Analogues From April to August After Bringing Synthetic Nicotine Under Tobacco Law
South Korea's liquid-vape market is showing changes across raw-material imports, product types and sales channels after synthetic nicotine came under the Tobacco Business Act on April 24. Customs data show nicotine-analogue imports totaled 12,126 kilograms from April through August, while synthetic-nicotine imports over the same five months totaled 231,663 kilograms, just 39.3% of the amount imported in March alone. Physical liquid-vape stores tracked in Seoul and Gyeonggi Province fell 9.9%, unmanned outlets edged higher and online sales listings increased from 27,774 to 42,437. Government testing of 105 liquid inhalation products promoted as nicotine-free separately found nicotine in 13 and 6-methylnicotine in 12.
Sep.22
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
GSTHR Estimates 200 Million People Use Non-Combustible Nicotine Products as 28 Countries Show Rising Use Alongside Falling Smoking Rates
The Global State of Tobacco Harm Reduction, a project operated by Knowledge·Action·Change, estimates that about 200 million people worldwide use non-combustible nicotine products including vapes, heated tobacco, nicotine pouches and snus. Its 2026 report says use of these products rose alongside declining smoking rates in 28 countries it analyzed. The data do not establish that all 200 million users have quit smoking, nor do they prove a direct causal relationship. GSTHR also says regulatory restrictions on the products continue to expand in many markets.
Sep.10
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
PMI Showcases ZYN, IQOS and U.S. Investments at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Philip Morris International (PMI) showcased its ZYN nicotine pouches, IQOS heated tobacco products and U.S. investments. A 2Firsts review of FDA records found that several ZYN products displayed at the booth were not on the agency's marketing authorization list, including certain nicotine strengths and flavors. A PMI booth representative also confirmed that IQOS is currently sold in three U.S. states, while the newer IQOS ILUMA system remains under FDA review.
EXPO
Oct.10